.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
QuintilesIMS
Harvard Business School
McKinsey
Chubb
Moodys
Novartis
Johnson and Johnson
Argus Health
Mallinckrodt

Generated: December 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 014740

« Back to Dashboard

NDA 014740 describes MENRIUM 5-4, which is a drug marketed by Roche and is included in one NDA. Additional details are available on the MENRIUM 5-4 profile page.

The generic ingredient in MENRIUM 5-4 is chlordiazepoxide; estrogens, esterified. There are eight drug master file entries for this compound. Additional details are available on the chlordiazepoxide; estrogens, esterified profile page.

Summary for 014740

Tradename:3
Applicant:1
Ingredient:1
Patents:0
Formulation / Manufacturing:see details

Summary for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength5MG;0.2MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Summary for product number 004

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength5MG;0.4MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Summary for product number 006

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength10MG;0.4MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Expired Orange Book Patents for NDA: 014740

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
RocheMENRIUM 5-2chlordiazepoxide; estrogens, esterifiedTABLET;ORAL014740-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
RocheMENRIUM 10-4chlordiazepoxide; estrogens, esterifiedTABLET;ORAL014740-006Approved Prior to Jan 1, 1982► Subscribe► Subscribe
RocheMENRIUM 5-4chlordiazepoxide; estrogens, esterifiedTABLET;ORAL014740-004Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Healthtrust
Boehringer Ingelheim
Farmers Insurance
Novartis
Moodys
Baxter
Merck
Citi
AstraZeneca
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot